How ancient viruses could help fight antibiotic resistance
As more bacteria evolve to withstand our antibiotics, previously treatable infections are becoming harder – and in some cases, impossible – to cure. This crisis, known as antimicrobial resistance (AMR), already causes over a million deaths a year globally, and the number is rising fast. The World Health Organization has named AMR one of the top ten global public health threats.
Phage therapy – the use of phages to treat bacterial infections – is gaining attention as a potential solution. Phages are highly specific, capable of targeting even drug-resistant strains. In some compassionate-use cases in the UK , they have cleared infections where every antibiotic had failed. But phages still face a challenge that is often overlooked: the bacteria themselves.
Bacteria have evolved sophisticated systems to detect and destroy phages. These defences are diverse: some cut up viral DNA, others block entry, and a few launch a kind of intracellular shutdown to prevent viral takeover. In a new study published in Cell , my colleagues and I describe a system that works differently, called Kiwa. It acts like a sensor embedded in the bacterial membrane, detecting early signs of attack.
Exactly what Kiwa is sensing remains an open question, but our findings suggest it responds to the mechanical stress that occurs when a phage latches on to the cell and injects its DNA. Once triggered, Kiwa acts fast. It shuts down the phage's ability to make the components it needs to build new phages, stopping the infection before it can take over the cell.
But just as bacteria evolve ways to defend themselves, phages evolve ways to fight back. In our latest experiments, we saw two strategies in play.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
Scientists use AI-designed proteins to generate immune cells
A team of Harvard scientists has used artificial intelligence (AI), in the form of AI-designed proteins, to generate large numbers of immune cells and enhance immunity against diseases ranging from cancer to viral infections, a new research paper published in Cell said. The scientists engineered a synthetic activator of a key cellular pathway called Notch signalling, which plays a crucial role in cellular differentiation and is essential for transforming human immune progenitors into T cells. Notch signalling is a cell-to-cell communication system vital for various developmental processes and tissue homeostasis in multicellular organisms. Homeostasis is the body's way of keeping everything balanced and stable, despite what is happening around it. 'In response to viral infections or cancer, the body requires a higher production of T cells to mount an effective immune defence. However, this process depends on the activation of the Notch signalling pathway, for which no effective molecular activators have been available,' Rubul Mout from Assam, the principal scientist of the study, said. Associated with the Harvard Stem Cell Institute and the Stem Cell & Regenerative Biology Program at Boston Children's Hospital, he is one of 24 scientists involved in the collaborative effort. They include George Daley, the Dean of Harvard Medical School, and Nobel laureate David Baker. Improved method According to the study, an earlier method of activating Notch signalling in laboratory settings by immobilising Notch ligands on tissue culture dishes is not applicable for therapeutic use in humans. The quest for a viable, soluble activator of Notch signalling that could work in vivo (inside a living body) made the team develop a library of custom-designed soluble Notch agonists and systematically test their ability to activate the Notch pathway and support T cell development and function. AI-driven protein design technologies, an innovation that contributed to Dr Baker receiving the 2024 Nobel Prize in Chemistry along with Demis Hassabis and John Jumper, were used to address the challenge. Using the agonists, the researchers demonstrated the large-scale generation of T cells in a laboratory bioreactor, an important advancement given the growing demand for T cell production in hospitals worldwide for Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapies. Furthermore, when the agonists were injected into mice during vaccination, the animals displayed significantly improved T cell responses, indicating an enhanced immune response. The treatment resulted in increased production of memory T cells, which are crucial for the long-term impact of vaccines. 'Being able to activate Notch signalling opens up tremendous opportunities in immunotherapy, vaccine development, and immune cell regeneration,' Dr Mout said. 'What excites me the most is using this technology to engineer synthetic proteins that simultaneously bridge T cells and cancer cells, boost T cell-mediated killing, and neutralise the immunosuppressive tumour micro-environment. Our goal is to develop next-generation immunotherapies and cancer vaccines,' he added. The other collaborators of the study include Urban Lendahl of the Stockholm-based Karolinska Institutet and a former Chairman of the Physiology and Medicine Nobel Committee, Stephen C. Blacklow, the Chair of Harvard Medical School's Department of Biological Chemistry and Molecular Pharmacology, and R. Grant Rowe of Boston's Dana-Farber Cancer Institute.
Time of India
3 hours ago
- Time of India
Age 50 might be inflexion point after which ageing accelerates, blood vessels vulnerable: Study
New Delhi: Analysing samples of human tissues across five decades, researchers have found that age 50 might be an inflexion point, after which ageing accelerates -- blood vessels age early and are markedly vulnerable, they said. The findings, published in the journal Cell, add to evidence emerging from analysing proteins from humans to understand ageing processes, researchers from the Chinese Academy of Sciences said. A study published last year in August in the journal Nature Ageing showed that ages 44 and 60 might be when a human body experiences changes in molecules and microbes, significantly impacting heart and immune function. The 'Cell' study looked at over 500 samples from 13 human tissues taken from organs across the body's systems, including the cardiovascular, immune and digestive. Proteomics, or a large-scale study of proteins, was applied to examine the samples that had aged over a period of 50 years. Results "revealed an ageing inflexion around age 50, with blood vessels being a tissue that ages early and is markedly susceptible to ageing." Further, based on changes in the proteins due to ageing, the authors have developed protein-based age clocks and charted the ageing trajectories of varied organs. The findings also highlighted an early and pronounced ageing of the aorta -- a major artery that carries blood from the heart to branch arteries -- which the authors said was critical to the ageing of blood vessels and in initiating ageing across the body by interacting with other organs and blood. "We introduce protein-based ageing clocks and dynamic ageing trajectories for human organs, illuminating their biological age and disease risks," the team wrote. They added, "Our study highlights the early and pronounced ageing of the aorta, underscoring the critical role of vascular senescence in initiating systemic ageing through its extensive interactions with other organs and blood components." PTI KRS HIG
NDTV
18 hours ago
- NDTV
Lung Cancer No More Smokers' Disease: Experts Reveal How Everyone Is Affected, Even Children
August 1 is annually observed as World Lung Cancer Day to raise awareness about the type of cancer that originates in the lungs and spreads to other parts of the body. Smoking is one of the primary causes of lung cancer, but alarming trends suggest that lung cancer can "no longer be seen as a smoker's disease" as it is affecting men, women and even children who don't smoke. "While smoking remains the leading cause, globally and in India, a concerning number of patients diagnosed today have never smoked a cigarette, and it's on the rise," Dr Srivatsa Lokeshwaran, Lead Consultant and Head of Department - Interventional Pulmonology and Lung Transplant, Aster Whitefield Hospital, Bengaluru, told NDTV. This growing trend is supported by Indian studies and global data that suggests a change being driven by environmental, occupational and/or genetic risk factors. A Lancet study, published in 2022, found that long-term exposure to fine particulate matter (PM2.5) caused an increase in the incidence rate of non-small cell lung cancer in non-smokers in urban and industrialised regions. In most Indian cities like Delhi, Bengaluru, and Kanpur, pollution levels have become too high to be considered acceptable by the World Health Organization (WHO). Air pollution would not merely irritate lung tissues; it can also damage DNA, thus, potentially creating cancer by the chronic exposure to pollutants such as soot, nitrogen dioxide, and benzene. Are Children At Risk? Can They Get Lung Cancer Or Other Severe Lung Diseases? Dr Shishir Bhatnagar, Senior Consultant - Paediatrician and Neonatologist at Cloudnine Group of Hospitals, Noida, told NDTV that lung cancer as such in children is "not very common". The cancers in the lungs are basically carcinoids, adenocarcinomas and subtle pleuropulmonary blastomas. Most of these cancers may have their origin rarely from smoking and genetic factors. "More commonly in children, the lungs are affected by inflammation and infections. The inflammations are basically contributory and they are responsible for creating conditions like asthma and bronchitis," Dr Bhatnagar said. "Infections like bronchopneumonias, bronchitis, bacterial bronchitis and bronchiolitis are also contributed to by the environmental factors, including smoking and environmental smoke and dust." The smoking at the microbiological level can affect the immune system and weaken it by affecting the annular macrophage system. It also disturbs the microbiome of the airways, thereby increasing the biological injuries in them. At the cellular level, it affects the DNA and makes it more prone to inflammation and cancer. According to Dr Bhatnagar, the bigger issue is the serious lung harm from environmental exposures during early childhood. Children who live in high pollution neighbourhoods, and/or have been exposed to passive smoke, unclean fuels, or multiple respiratory infections as infants, potentially have sustained damage to their lungs, some of which may lead to chronic disease (bronchiectasis, asthma, lung cancer) in the future. A study published in 2023 in The New England Journal of Medicine demonstrated that children exposed to high levels of PM2.5, impaired lung function, asymmetrically slowed lung development, and had the potential for life-long impairment related to lung function. Serious Concerns Over Vaping Experts are also concerned about the rising trend of vaping. Dr Bhatnagar said that vaping is some sort of mechanism where the toxins produced are less and are not equivalent to smoking. "The toxins are less, but they have high nicotine dependence. There are very high chances that in adolescence this can become a trouble, and it is actually a problem these days," he said, further adding that vaping can contribute and can actually go on to smoking. "Children may not have early symptoms of cancer, but a persistent cough, wheezing without being diagnosed with asthma, recurrence of pneumonia, or even chest pain of unknown origin, must be taken seriously," Dr Bhatnagar said. Children must be protected from indoor air pollution, and also reduce exposure to passive smoke, while treating infections early, as lung health is often forgotten. Major Causes Of Lung Cancer The most frequent cause is smoking, responsible for more than 70 per cent of cases and 90 per cent of diagnoses. "Tobacco smoke harbours more than 60 carcinogens, and the risk is directly proportional to the intensity of smoking. The world's second-largest consumer of tobacco is India, which has 267 million consumers of tobacco, and tobacco is responsible for 27% of all cancers," Dr Vinayak Maka, Consultant - Dept of Medical Oncology, Ramaiah Institute of Oncosciences, Ramaiah Memorial Hospital, told NDTV. For all causes except tobacco, environmental and occupational risk factors are important: Passive Smoking: Significantly boosts risk. Radon Gas: The Second greatest risk factor after smoking, particularly in smokers. Occupational Exposure: Chemicals like asbestos, arsenic, and beryllium raise risk, especially among smokers. Genetic Influence: Family health history is one of the major contributing factors in making a person more vulnerable. Air Pollution: A high-risk factor; Delhi alone has witnessed an increase in lung cancer cases due to pollution. Diet and Processed Foods: Studies have found that an intake of ultra-processed foods leads to a 41 per cent higher risk, undermining the role played by diet. Regular Screening And Early Detection Dr Raja Dhar, Director & HOD - Pulmonology, CMRI Kolkata, weighed in on the strength of regular screening and early detection. He told NDTV, "Regular screening is also key, particularly for those at greater risk, because it enables us to catch problems early on, when treatment works best. Lung cancer too often gets diagnosed too late, but if we can detect it early, the likelihood of successful treatment is greatly enhanced."
